Skip header and navigation
Did you mean topic:"immunothepary"? Also try immunothepary.

Narrow By

32 records – page 1 of 2.

Advances in tumor immunology and immunotherapy

https://libcat.nshealth.ca/en/permalink/provcat33290
Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa, editors. --New York: Springer , c2014.
Available Online
View e-Book
Location
Online
Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. Enhanced understanding of mechanisms underlying T-cell anergy such as arginine deprivation, immunosuppressive cytokines, defective innate and interferon res…
Available Online
View e-Book
Other Authors
Rosenblatt, Joseph D
Responsibility
Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa, editors
Place of Publication
New York
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (ix, 371 pages)
Series Title
Current cancer research
ISBN
9781461488095 (electronic bk.)
9781461488088
Subjects (MeSH)
Antigens, Neoplasm - immunology
Neoplasms - immunology
Neoplasms - therapy
T-Lymphocytes, Cytotoxic - immunology
Immunotherapy - methods
Subjects (LCSH)
Tumors - Immunological aspects
Cancer - Immunological aspects
Antigens, Neoplasm - immunology
Neoplasms - therapy
T-Lymphocytes, Cytotoxic - immunology
Cancer - Immunotherapy
Neoplasms - Immunology
Abstract
Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. Enhanced understanding of mechanisms underlying T-cell anergy such as arginine deprivation, immunosuppressive cytokines, defective innate and interferon response pathways, and NKG2D downregulation have all provided new insight into suppression of anti-tumors.
Contents
Part I. Immune Activation, Suppression and Manipulation of the Immune Antitumor Response -- Myeloid-Derived Suppressor Cells in Cancer -- The Role of B Cells in Shaping the Antitumor Immune Response -- Heat-Shock Protein-Based Cancer Immunotherapy -- Activation of NK Cell Responses and Immunotherapy of Cancer -- Induction of Tumor Immunity by Targeted Inhibition of Nonsense-Mediated mRNA Decay -- Employing T Cell Homeostasis as an Antitumor Strategy -- Adoptive Cell Therapy of Systemic Metastases Using erbB-2-Specific T Cells Redirected with a Chimeric Antibody-Based Receptor -- Part II. Evolving Clinical Immunotherapeutic Strategies -- Immunotherapy in Renal Cell Carcinoma -- Adoptive T-Cell Transfer as a Clinical Antitumor Strategy for Hematologic Malignancies -- Bifunctional Antibodies: Preclinical and Clinical Applications -- Clinical Development of Antibody-Fusion Proteins for Cancer Therapy -- Immunologic Outcomes of Allogeneic Stem Cell Transplantation: Graft-Versus-Host and Graft-Versus-Leukemia Responses and Implications for Future Therapy -- The Immune System in Head and Neck Squamous Cell Carcinoma: Interactions and Therapeutic Opportunities -- T Cell Co-regulatory Signals and Their Role in Cancer Therapy -- Assessment of Immune Response in Biotherapy Trials and Clinical Endpoints.
Format
e-Book
Location
Online
Less detail

Atlas of Response to Immunotherapy

https://libcat.nshealth.ca/en/permalink/provcat45029
Egesta Lopci, Stefano Fanti, editors. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with relia…
Available Online
View e-Book
Other Authors
Lopci, Egesta
Fanti, Stefano
Responsibility
Egesta Lopci, Stefano Fanti, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (viii, 127 p.) : 111 illus., 100 illus. in color
ISBN
9783030311131
9783030311124 (Print ed.)
9783030311148 (Print ed.)
9783030311155 (Print ed.)
Subjects (MeSH)
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
Positron Emission Tomography Computed Tomography
Treatment Outcome
Specialty
Biological Therapy
Medical Oncology
Abstract
This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment. A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases. To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy. The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario. The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.
Contents
Part I. Brief Introduction -- 1. Immunotherapy in Oncology -- 2. Evolution of Response Criteria in Immunotherapy -- Part II. Disease-Oriented Applications -- 3. CNS Tumors: PET/CT and MRI for Response Assessment of CNS Tumors Following Immunotherapy -- 4. Lung Cancer: 18F-FDG PET/CT for Response Assessment of Lung Following Immunotherapy -- 5. Malignant Pleural Mesothelioma: 18F-FDG PET/CT for Response Assessment of Malignant Pleural Mesothelioma Following Immunotherapy -- 6. Melanoma: 18F-FDG PET/CT for Response Assessment of Melanoma Following Immunotherapy -- 7. Genitourinary Tumors: PET/CT for Response Assessment of Genitourinary Tumors Following Immunotherapy -- 8. Hematologic Malignancies: PET/CT for Response Assessment of Hematologic Malignancies Following Immunotherapy -- 9. Other Tumor Types: 18F-FDG PET/CT for Response Assessment of Various Tumors Following Immunotherapy -- Part III. Potential Pitfalls to Response Assessment -- 10. Pitfalls and Immune-Related Adverse Events -- Part IV. New Radiopharmaceuticals -- 11. ImmunoPET: The Future of Response Evaluation for Cancer Immunotherapy.
Format
e-Book
Publication Type
Atlas
Location
Online
Less detail

Cancer Immunology : Bench to Bedside Immunotherapy of Cancers

https://libcat.nshealth.ca/en/permalink/provcat39431
Nima Rezaei, editor. --Berlin, Heidelberg: Springer , c2015.
Available Online
View e-Book
Location
Online
This translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem cells, hematopoietic stem cell transplantation, the…
Available Online
View e-Book
Other Authors
Rezaei, Nima
Responsibility
Nima Rezaei, editor
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (l, 485 p. : 45 illus., 38 illus. in color)
ISBN
9783662449462
9783662449455 (print ed.)
Subjects (MeSH)
Immunotherapy - methods
Neoplasms - therapy
Abstract
This translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem cells, hematopoietic stem cell transplantation, the role of T lymphocytes in cancer immunotherapy, use of monoclonal antibodies, and many more innovative approaches. Clinical immunologists, hematologists, and oncologists in particular will find the book to be of value in expanding their knowledge. The book is the second in a three-volume series, Cancer Immunology, which offers an up-to-date review of cancer immunology and immunotherapy. The remaining volumes focus on the immunopathology of cancers and cancer immunotherapy for organ-specific tumors. In total the series, designed for both clinicians and researchers, includes contributions from more than 250 scientists working at leading universities and institutes from across the world.
Contents
Frontiers in Cancer Immunotherapy -- Novel Strategy of Cancer Immunotherapy: Spiraling Up -- Novel Prognostic Biomarkers for Personalized Cancer Treatments -- Tumor Antigen and Epitope Identification for Pre-Clinical and Clinical Evaluation -- Strategies to Target Tumor Immunesuppression -- Immune Modulation of Drugs in Prevention and Treatment of Cancers -- Overcoming Immune Tolerance With Immune Checkpoint Blockade -- Gene therapy and Virus-Based Cancer Vaccines -- Cancer Stem Cells: Biology and Potential therapeutic Applications -- Hematopoietic Stem Cell Transplantation and Lymphodepletion in Treatment of Cancers -- Combination of Chemotherapy and Cytokine Therapy in Treatment of Cancers -- T Cell Immunotherapy: From Synthetic Biology to Clinical Practice -- Role of Gamma-Delta T Lymphocytes in Cancer Immunosurveillance and Immunotherapy -- Adoptive T Cell therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy -- Cellular therapy of Cancer With B Effector Cells -- Monoclonal Antibodies for Treatment of Cancers -- Pattern Recognition Receptors in Cancers and Immunotherapy by Triggering or Targeting of Toll Like Receptors Pathway -- Recent Advances in the Use of NK Cells Against Cancer -- Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials -- Tumor Associated Macrophages and iNOS in Cancer Immunotherapy -- Photodynamic therapy and Anti-Tumor Immune Response -- Polarization of Tumor Milieu: Therapeutic Implications -- Immunotherapies Targeting 5T4 Oncofoetal Glycoprotein -- Immune Monitoring During Clinical Development of Anti-CTLA-4 Antibody Therapy -- PD-1 Blockade in Cancer Therapy -- New Advances in Radioimmunotherapy for the Treatment of Cancers -- Psychoneuroendocrinoimmunotherapy of Cancers -- Ethical Considerations in Cancer Immunotherapy.
Format
e-Book
Location
Online
Less detail

Cancer Immunology : Bench to Bedside Immunotherapy of Cancers

https://libcat.nshealth.ca/en/permalink/provcat46359
Nima Rezaei, editor. (Second edition) --Cham: Springer , c2021.
Available Online
View e-Book
Access
NEW Springer 2021
Location
Online
This translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow …
Available Online
View e-Book
Other Authors
Rezaei, Nima
Responsibility
Nima Rezaei, editor
Edition
Second edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2021
Physical Description
1 online resource (xl, 658 p.) : 53 illus., 46 illus. in color
ISBN
9783030502874
9783030502867 (Print ed.)
9783030502881 (Print ed.)
9783030502898 (Print ed.)
Subjects (MeSH)
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
Specialty
Allergy and Immunology
Medical Oncology
Regenerative Medicine
Abstract
This translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy. The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and cancer immunotherapy for organ-specific tumors. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers will be of special value to clinical immunologists, hematologists, and oncologists.
Contents
Frontiers in Cancer Immunotherapy -- Novel Strategy of Cancer Immunotherapy: Spiraling Up -- Novel Prognostic Biomarkers for Personalized Cancer Treatments -- Tumor Antigen and Epitope Identification for Pre-Clinical and Clinical Evaluation -- Strategies to Target Tumor Immunesuppression -- Immune Modulation of Drugs in Prevention and Treatment of Cancers -- Overcoming Immune Tolerance With Immune Checkpoint Blockade -- Gene therapy and Virus-Based Cancer Vaccines -- Cancer Stem Cells: Biology and Potential therapeutic Applications -- Hematopoietic Stem Cell Transplantation and Lymphodepletion in Treatment of Cancers -- Combination of Chemotherapy and Cytokine Therapy in Treatment of Cancers -- T Cell Immunotherapy: From Synthetic Biology to Clinical Practice -- Role of Gamma-Delta T Lymphocytes in Cancer Immunosurveillance and Immunotherapy -- Adoptive T Cell therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy -- Cellular therapy of Cancer With B Effector Cells -- Monoclonal Antibodies for Treatment of Cancers -- Pattern Recognition Receptors in Cancers and Immunotherapy by Triggering or Targeting of Toll Like Receptors Pathway -- Recent Advances in the Use of NK Cells Against Cancer -- Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials -- Tumor Associated Macrophages and iNOS in Cancer Immunotherapy -- Photodynamic therapy and Anti-Tumor Immune Response -- Polarization of Tumor Milieu: Therapeutic Implications -- Immunotherapies Targeting 5T4 Oncofoetal Glycoprotein -- Immune Monitoring During Clinical Development of Anti-CTLA-4 Antibody Therapy -- PD-1 Blockade in Cancer Therapy -- New Advances in Radioimmunotherapy for the Treatment of Cancers -- Psychoneuroendocrinoimmunotherapy of Cancers -- Ethical Considerations in Cancer Immunotherapy.
Access
NEW Springer 2021
Format
e-Book
Location
Online
Less detail

Cancer Immunology : Cancer Immunotherapy for Organ-Specific Tumors

https://libcat.nshealth.ca/en/permalink/provcat39456
Nima Rezaei, editor. --Berlin, Heidelberg: Springer , c2015.
Available Online
View e-Book
Location
Online
Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume focuses on the immunopathology and immunotherapy of organ cancers in detail. It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers, bone and connective tissue tumors, central nervous system tumors, lung cancers, genitourinary tract tum…
Available Online
View e-Book
Other Authors
Rezaei, Nima
Responsibility
Nima Rezaei, editor
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xliii, 488 p. : 48 illus., 44 illus. in color)
ISBN
9783662464106
9783662464090 (print ed.)
Subjects (MeSH)
Immunomodulation
Immunotherapy - methods
Neoplasms - therapy
Organ Specificity
Abstract
Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume focuses on the immunopathology and immunotherapy of organ cancers in detail. It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers, bone and connective tissue tumors, central nervous system tumors, lung cancers, genitourinary tract tumors, and breast cancers. In so doing, it builds on the previous two volumes in Cancer Immunology, placing basic knowledge on tumor immunology and immunotherapy into a clinical perspective with the aim of educating clinicians on advances in cancer immunology and the most recent approaches in the immunotherapy of various tumors. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists, and oncologists.
Contents
Specific Organ Tumors: General Considerations On Immunotherapy -- Vaccination Of Human Solid Tumors: Recent Progress In The Clinical Setting -- Immunotherapy For Pediatric Solid Tumors -- Immunopathology Of Hematological Cancers And Immunotherapy Of Leukemia And Multiple Myeloma -- Immunopathology Of Lymphoma And Immunotherapy Of Hodgkin's Disease And Non-Hodgkin's Lymphoma -- Cancer-Testis Antigens As Targets For The Immunotherapy Of Hematological Malignancies -- Tumor Immunology And Immunotherapy Of Gastrointestinal Tract Cancers -- Immunology And Immunotherapy Of Colorectal Cancer -- Immunopathology Of Hepatobiliary Tumors And Immunotherapy Of Liver Cancers -- Immunology And Immunotherapy Of Pancreatic Tumors -- Immunology Of Cutaneous Tumors And Immunotherapy For Melanoma -- Immunopathology Of Head And Neck Tumors And Immunotherapy Of Squamous Cell Carcinoma -- Immunopathology And Immunotherapy Of Oral Cancers -- Immunopathology Of Bone And Connective Tissue Cancers And Immunotherapy Of Sarcomas -- Immunopathology Of Central Nervous System Cancers And Immunotherapy Of Brain Tumors -- Immunology And Immunotherapy Of Pulmonary Tumors -- Immunopathology Of Urinary System Cancers And Immunotherapy Of Renal And Bladder Cancers -- Immunopathology Of Cancers Of Male And Female Genitalia Organs And Immunotherapy Of Cervical And Prostate Cancer -- Immunology And Immunotherapy Of Ovarian Cancer -- Revisiting Immunology For Breast Cancer -- Immunology And Immunotherapy Of Graft Versus Host Disease.
Format
e-Book
Location
Online
Less detail

Cancer Immunology : Cancer Immunotherapy for Organ-Specific Tumors

https://libcat.nshealth.ca/en/permalink/provcat46145
Nima Rezaei, editor. (Second edition) --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book explains the immunology of organ-specific malignancies and discusses novel immunotherapy strategies for their treatment. Since the first, very successful edition of the book was published in 2015, a number of entirely new chapters have been included. The range of cancers considered has accordingly been extended, with coverage of the latest immunotherapy approaches for skin cancers, ocular malignancies, endocrine malignancies, cardiac cancers, vascular cancers, and HPV-associated cance…
Available Online
View e-Book
Other Authors
Rezaei, Nima
Responsibility
Nima Rezaei, editor
Edition
Second edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xxx, 581 p.) : 34 illus., 30 illus. in color
ISBN
9783030579494
9783030579487 (Print ed.)
9783030579500 (Print ed.)
9783030579517 (Print ed.)
Subjects (MeSH)
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
Specialty
Allergy and Immunology
Medical Oncology
Abstract
This book explains the immunology of organ-specific malignancies and discusses novel immunotherapy strategies for their treatment. Since the first, very successful edition of the book was published in 2015, a number of entirely new chapters have been included. The range of cancers considered has accordingly been extended, with coverage of the latest immunotherapy approaches for skin cancers, ocular malignancies, endocrine malignancies, cardiac cancers, vascular cancers, and HPV-associated cancers. In addition, the original chapters have been updated to document the latest advances in immunotherapy for pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, bone tumors, CNS tumors, lung cancer, genitourinary tract tumors, and breast cancer, among others. The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists.
Contents
1. Cancer Immunotherapy Confers a Global Benefit -- 2. Immunotherapy for Pediatric Solid Tumors -- 3. Immunotherapeutic Strategies for Multiple Myeloma -- 4. Immunopathology and Immunotherapy of Myeloid Leukemia -- 5. Immunopathology and Immunotherapy of Acute Lymphoblastic Leukemia -- 6. Immunopathology and Immunotherapy of Hodgkin Lymphoma -- 7. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma -- 8. Immunotherapy of Gastric and Esophageal Cancers -- 9. Hepatobiliary Tumors: Immunopathology and Immunotherapy -- 10. Immunology and Immunotherapy of Colorectal Cancer -- 11. Immunotherapy in Nonmelanoma Skin Cancers -- 12. Immunopathology and Immunotherapy of Melanoma -- 13. Immunopathology as a Basis for Immunotherapy of Head and Neck Squamous Cell Carcinoma -- 14. Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoe -- 15. Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas -- 16. Immunopathology and Immunotherapy of Central Nervous System Cancer -- 17. Immunotherapy of Lung Tumors -- 18. Immunotherapy in Bladder and Renal Cancers -- 19. Immunopathology of Specific Cancers in Males and Females and Immunotherapy of Prostate and Cervical Cancer -- 20. Immunology and Immunotherapy of Ovarian Cancer -- 21. Immunopathology and Immunotherapy for Breast Cancer -- 22. Immunology and Immunotherapy of Graft-Versus-Host Disease.
Format
e-Book
Location
Online
Less detail

Cancer immunotherapy : immune suppression and tumor growth

https://libcat.nshealth.ca/en/permalink/provcat27591
Pendergast, George C. --Amsterdam, Netherlands: Elsevier Academic Press , 2007.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Pendergast, George C
Other Authors
Jaffee, Elizabeth M
Place of Publication
Amsterdam, Netherlands
Publisher
Elsevier Academic Press
Date of Publication
2007
Physical Description
409 p.
ISBN
9780080521855
Subjects (MeSH)
Antineoplastic Agents - therapeutic use
Immunotherapy
Neoplasms - therapy
Contents
Cancer immunoediting: from immune surveillance to immune escape / Ryungsa Kim -- Immunosurveillance: innate and adaptive antitumor immunity / Masahisa Jinushi and Glenn Dranoff -- Cytokine regulation of immune tolerance to tumors / Ming O. Li and Richard A. Flavell -- Immunological sculpting: natural killer cell receptors and ligands / David A. Sallman and Julie Y. Djeu -- Immune escape: immunosuppressive networks / Shuang Wei, Alfred Chang, and Weiping Zou -- Cytotoxic chemotherapy in clinical treatment of cancer / Rajesh Thirumaran, George C. Prendergast, and Paul B. Gilman -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Concepts in pharmacology and toxicology / Richard A. Westhouse and Bruce D. Car -- Cancer immunotherapy: challenges and opportunities / Andrew J. Lepisto, John R. McKolanis, and Olivera J. Finn -- Cancer vaccines / Freda K. Stevenson ... [et al.] -- Immunotherapy and cancer therapeutics: why partner? / Leisha A. Emens and Elizabeth M. Jaffee -- Immune stimulatory features of classical chemotherapy / Robbert G. van der Most, Anna K. Nowak, and Richard A. Lake -- Dendritic cells and coregulatory signals: immune checkpoint blockade to stimulate immunotherapy / Drew Pardoll -- Regulatory T cells in tumor immunity: role of toll-like receptors / Rong-Fu Wang -- Tumor-associated macrophages in cancer growth and progression / Alberto Mantovani, Paola Allavena and Antonio Sica -- Tumor-associated myeloid-derived suppressor cells / Stephanie K. Bunt ... [et al.] -- Programmed death ligand-1 and galectin-1: pieces in the puzzle of tumor-immune escape / Gabriel A. Rabinovich and Thomas F. Gajewski -- Indoleamine 2,3-dioxygenase in immune escape: regulation and therapeutic inhibition / Alexander J. Muller and George C. Prendergast -- Arginase, nitric oxide synthase, and novel inhibitors of L-arginine metabolism in immune modulation / Susanna Mandruzzato, Simone Mocellin, and Vincenzo Bronte.
Format
e-Book
Location
Online
Less detail

Cancer immunotherapy meets oncology : in honor of Christoph Huber

https://libcat.nshealth.ca/en/permalink/provcat33730
Cedrik Michael Britten, Sebastian Kreiter, Mustafa Diken, Hans-Georg Rammensee, editors. --Heidelberg: Springer , c2014.
Available Online
View e-Book
Location
Online
This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical developmen…
Available Online
View e-Book
Other Authors
Britten, Cedrik Michael
Huber, Christoph
Responsibility
Cedrik Michael Britten, Sebastian Kreiter, Mustafa Diken, Hans-Georg Rammensee, editors
Place of Publication
Heidelberg
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (ix, 248 pages)
ISBN
9783319051048 (electronic bk.)
9783319051031
Subjects (MeSH)
Immunotherapy
Neoplasms - immunology
Neoplasms - therapy
Tumor Markers, Biological
Subjects (LCSH)
Cancer - Immunotherapy
Oncology
Cancer Research
Pharmacology/Toxicology
Immunology
Abstract
This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing. Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients.
Contents
Part I. Immunological and Regulatory Framework for Immuno-oncology -- From Basic Immunology to New Therapies for Cancer Patients -- How T Cells Single Out Tumor Cells: "And That Has Made All the Difference" -- Effects of Regulatory T Cell-Dendritic Cell Interactions on Adaptive Immune Responses -- Evolution of the Regulatory Landscape for Immunomodulatory Compounds and Personalized Therapeutic Cancer Vaccines -- Immunoguiding, the Final Frontier in the Immunotherapy of Cancer -- Developing Cancer Immunotherapies as Drugs: Setting the Stage Through Methodological Progress -- Part II. Immunotherapies -- Reflections on Cancer Vaccines -- Dendritic Cell-Based Cancer Vaccines -- mRNA Vaccination and Personalized Cancer Therapy -- Antibody Therapy in Oncology -- Bispecific Antibodies for the Treatment of Cancer: The Challenges of Translation -- The ABCs of T Cell Receptor Gene Therapy -- The Express Drivers: Chimeric Antigen Receptor-Redirected T Cells Make It to the Clinic -- Part III. Cancer Entities -- Immunotherapy of Malignant Melanoma -- Prostate Cancer Vaccines Generated with the Disruptive RNActive® Technology Follow the Path Paved by Sipuleucel-T and Prostvac-VF -- Recent Developments in the Active Immunotherapy of Renal Cell Cancer -- Current Status of Immunotherapy in Gastroesophageal Cancer -- Non-small Cell Lung Cancer, NSCLC -- Towards More Specificity and Effectivity in the Antileukemia Immune Response -- Part IV. Biomarkers -- Molecular and Metabolic Cues of the Key-Lock Paradigm Dictating Immunogenic Cell Death -- Pathogenesis of Minimal Residual Disease: CTCs as Novel Biomarkers in Cancer Disease -- Genomics Meets Cancer Immunotherapy -- Part V. Featured Chapters -- Oncolytic Viruses -- Part VI. Final Remarks -- Final Words.
Format
e-Book
Location
Online
Less detail

Chemotherapy and immunotherapy guidelines and recommendations for practice

https://libcat.nshealth.ca/en/permalink/provcat43752
edited by MiKaela Olsen, Kristine B. LeFebvre, and Kelly J. Brassil. --Pittsburgh, PA: Oncology Nursing Society , c2019.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Olsen, MiKaela
Responsibility
edited by MiKaela Olsen, Kristine B. LeFebvre, and Kelly J. Brassil.
Alternate Title
Chemotherapy and immunotherapy guidelines & recommendations for practice
Place of Publication
Pittsburgh, PA
Publisher
Oncology Nursing Society
Date of Publication
c2019
Physical Description
1 online resource
ISBN
9781635930214
Subjects (MeSH)
Antineoplastic Agents
Immunotherapy
Neoplasms - nursing
Neoplasms - therapy
Specialty
Medical Oncology
Pharmacology
Format
e-Book
Publication Type
Practice Guideline
Location
Online
Less detail

Chemotherapy and Immunotherapy in Urologic Oncology : A Guide for the Advanced Practice Provider

https://libcat.nshealth.ca/en/permalink/provcat46364
Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi, editors. --Cham: Springer , c2021.
Available Online
View e-Book
Access
NEW Springer 2021
Location
Online
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current…
Available Online
View e-Book
Other Authors
Trabulsi, Edouard J.
Lallas, Costas D.
Lizardi-Calvaresi, Anne E.
Responsibility
Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2021
Physical Description
1 online resource (xiv, 307 p.) : 22 illus., 19 illus. in color
ISBN
9783030520212
9783030520205 (Print ed.)
9783030520229 (Print ed.)
Subjects (MeSH)
Antineoplastic Agents - therapeutic use
Urologic Neoplasms - drug therapy
Immunotherapy - methods
Specialty
Medical Oncology
Pharmacology
Regenerative Medicine
Urology
Abstract
This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. .
Contents
Introduction: Integration of APP into Urologic Oncology Practice -- Part I. Prostate Cancer -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Part II. Bladder Cancer -- Bladder Cancer: Overview, Epidemiology, Initial Presentation and Diagnosis -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease, Neoadjuvant Chemotherapy, and Radical Cystectomy -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the Treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Part III. Kidney Cancer -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Part IV. Other Malignancies -- Testicular Cancer -- Penile Cancer.
Access
NEW Springer 2021
Format
e-Book
Location
Online
Less detail

Childhood Acute Lymphoblastic Leukemia

https://libcat.nshealth.ca/en/permalink/provcat41348
Ajay Vora, editor. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy. Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches. Supportive c…
Available Online
View e-Book
Other Authors
Vora, Ajay
Responsibility
Ajay Vora, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (ix, 342 pages) : 38 illus., 30 illus. in color
ISBN
9783319397085
9783319397078 (print ed.)
Subjects (MeSH)
Immunotherapy
Molecular Targeted Therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Abstract
This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy. Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches. Supportive care and management of the condition in resource poor countries are also discussed in detail. This is an indispensable guide for research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood leukemia.
Contents
1. Epidemiology and Etiology of Childhood ALL -- 2. Clinical Presentation and Prognostic Factors -- 3. Diagnostic Flow Cytometry and Immunophenotypic Classification -- 4. Cytogenetics and Molecular Genetics -- 5. Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Antileukemic Drugs -- 6. Minimal Residual Disease (MRD) Diagnostics: Methodology and Prognostic Significance -- 7. First Line Treatment: Current Approach -- 8. Targeted Therapy and Precision Medicine -- 9. Monoclonal Antibodies in Pediatric Acute Lymphoblastic Leukemia -- 10. Cellular Therapy -- 11. Relapsed Acute Lymphoblastic Leukemia of Childhood -- 12. Medical Supportive Care for Treatment-Related Toxicity in Childhood ALL -- 13. Developing World Perspective.
Format
e-Book
Location
Online
Less detail

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://libcat.nshealth.ca/en/permalink/provcat50487
Lee, Daniel W. (1st ed.) --Amsterdam, Netherlands: Elsevier , 2020.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Lee, Daniel W.
Other Authors
Shah, Nirali N.
Edition
1st ed.
Place of Publication
Amsterdam, Netherlands
Publisher
Elsevier
Date of Publication
2020
ISBN
9780323661812
Subjects (MeSH)
Immunotherapy, Adoptive
Genetic Therapy
Cell- and Tissue-Based Therapy
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Chimeric antigen receptor t-cell therapy

https://libcat.nshealth.ca/en/permalink/chpams37609
Nova Scotia Cell Therapy and Transplant Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2022.
Pamphlet Number
4035
Available Online
View Pamphlet
This booklet is a guide to help you better understand chimeric antigen receptor T-cell therapy (CAR T-cell therapy). Topics include what CAR T-cell therapy is, enrollment in the program, T-cell collection, monitoring/bridging therapy, chemotherapy (lymphodepletion), CAR T-cell infusion, monitoring post-cell infusion, key inpatient discharge information, information about long term follow-up care and care at home, ongoing side effects, and information for the CAR T-cell care partner. Information…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Cell Therapy and Transplant Program
Alternate Title
CAR t-cell therapy
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (44 p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - therapy
Immunotherapy, Adoptive
Subjects (LCSH)
Cancer--Treatment
T-cell receptor genes
Immunotherapy
Specialty
Cancer Care
Abstract
This booklet is a guide to help you better understand chimeric antigen receptor T-cell therapy (CAR T-cell therapy). Topics include what CAR T-cell therapy is, enrollment in the program, T-cell collection, monitoring/bridging therapy, chemotherapy (lymphodepletion), CAR T-cell infusion, monitoring post-cell infusion, key inpatient discharge information, information about long term follow-up care and care at home, ongoing side effects, and information for the CAR T-cell care partner. Information about Cell Therapy Transplant Program policies, the Medical Day Unit and Hematology Clinic, shingles, recommended vaccinations, and emotional support resources is included. A map of the QEII Health Sciences Centre Victoria General site is provided.
Responsibility
Prepared by: Nova Scotia Cell Therapy and Transplant Program
Pamphlet Number
4035
Less detail

Developments in T Cell Based Cancer Immunotherapies

https://libcat.nshealth.ca/en/permalink/provcat39372
Paolo A. Ascierto, David F. Stroncek, Ena Wang, editors. (1st ed.) --Cham: Springer International Publishing : Imprint: Humana Press , c2015.
Available Online
View e-Book
Location
Online
This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification …
Available Online
View e-Book
Other Authors
Ascierto, Paolo A
Stroncek, David F
Wang, Ena
Responsibility
Paolo A. Ascierto, David F. Stroncek, Ena Wang, editors
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Humana Press
Date of Publication
c2015
Physical Description
1 online resource (xv, 305 p. : 26 illus. in color)
Series Title
Cancer drug discovery and development
ISBN
9783319211671
9783319211664 (print ed.)
ISSN
2196-9906
Subjects (MeSH)
Immunity, Cellular - immunology
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
T-Lymphocytes - immunology
Abstract
This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.
Contents
1. Insights on Peptide Vaccines in Cancer Immunotherapy -- 2. Strategies for Improving Vaccines to Elicit T Cells to Treat Cancer -- 3. T Cell Fate in the Tumor Microenvironment -- 4 Influence of Antigen Receptor Avidity, Affinity, and Specificity on Genetically Engineered T Cells -- 5. Toward the Identification of Genetic Determinants of Responsiveness to Cancer Immunotherapy -- 6. Production of Clinical T Cell Therapies -- 7. Clinical Success of Adoptive Cell Transfer Therapy Using Tumor Infiltrating Lymphocytes -- 8. Harnessing Stem Cell-Like Memory T Cells for Adoptive Cell Transfer Therapy of Cancer -- 9. T Cell Blockade Immunotherapy Against Cancer and Abscopal Effect in Combination Therapy -- 10. T Cell Modulation: Anti-PD-1 Antibodies for the Treatment of Cancer -- 11. Enhancing T Cell Performance Against Cancer in Combination Treatment Strategies -- 12. Chimeric Antigen Receptor (CAR) T Cells -- 13. Rapamycin-Resistant T Cells and Pentostatin- Based Immuno-Selective Conditioning for the Allogeneic T Cell Therapy of Cancer.
Format
e-Book
Location
Online
Less detail

Early Phase Cancer Immunotherapy

https://libcat.nshealth.ca/en/permalink/provcat42936
Sandip Pravin Patel, Razelle Kurzrock, editors. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Available Online
View e-Book
Other Authors
Patel, Sandip Pravin
Kurzrock, Razelle
Responsibility
Sandip Pravin Patel, Razelle Kurzrock, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xi, 331 p.) : 24 illus., 15 illus. in color
Series Title
Current cancer research
ISBN
9783319637570
9783319637563 (print ed.)
9783319637587 (print ed.)
9783319876283 (print ed.)
ISSN
2199-2584
Subjects (MeSH)
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Immunotherapy - methods
Neoplasms - therapy
Specialty
Medical Oncology
Regenerative Medicine
Abstract
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Contents
1. Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- 2. Pharmacokinetics and Pharmacodynamics of Immunotherapy -- 3. Immunotherapeutic Biomarkers and Selection Strategies -- 4. Radiographic Evaluation of Immunotherapy -- 5. Cellular Therapy -- 6. Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- 7. Early Phase Cancer Immunotherapy -- 8. Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- 9. Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- 10. Thoracic Immunotherapy.
Format
e-Book
Location
Online
Less detail

Gene therapy of cancer

https://libcat.nshealth.ca/en/permalink/provcat50735
Lattime, Edmund. (3rd ed.) --Philadelphia, PA: Elsevier , 2014.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Lattime, Edmund
Edition
3rd ed.
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
2014
ISBN
9780123942951
Subjects (MeSH)
Neoplasms - genetics
Neoplasms - therapy
Genetic Therapy - methods
Immunotherapy - methods
Protein Biosynthesis - genetics
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Immune Checkpoint Inhibitors : A Guide for Cancer Patients

https://libcat.nshealth.ca/en/permalink/chpams37419
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1674
Available Online
View Pamphlet
This guide describes Immune Checkpoint Inhibitors (CPIs), why they are used, differences from other treatments, possible side effects, what precautions to take, and what to expect after treatment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Immune Checkpoint Inhibitors
Immunotherapy
Neoplasms - drug therapy
Subjects (LCSH)
Cancer--Chemotherapy
Cancer--Immunotherapy
Specialty
Pharmacy
Abstract
This guide describes Immune Checkpoint Inhibitors (CPIs), why they are used, differences from other treatments, possible side effects, what precautions to take, and what to expect after treatment.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1674
Less detail

Immunobiology : the immune system in health and disease

https://libcat.nshealth.ca/en/permalink/provcat53629
Janeway, Charles A. (4th ed.) --New York, NY: Current Biology Publications , 1999.
Call Number
QW 940 I73 1999
Location
IWK Health Sciences Library
Call Number
QW 940 I73 1999
Author
Janeway, Charles A.
Other Authors
Travers, Paul
Walport, Mark
Capra, J. Donald
Edition
4th ed.
Place of Publication
New York, NY
Publisher
Current Biology Publications
Date of Publication
1999
Physical Description
635 p.
ISBN
815332173
Subjects (MeSH)
Immune System - physiology
Immune System - physiopathology
Immunity
Immunotherapy
Format
Book
Location
IWK Health Sciences Library
Copies
1
Loan Period
2 weeks
Less detail

Immunotherapies for allergic disease

https://libcat.nshealth.ca/en/permalink/provcat44695
edited by Linda S. Cox. --Amsterdam, Netherlands: Elsevier , c2020.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Get a quick, expert overview of the use of current and novel immunotherapies for use in the management and treatment of allergic reactions and diseases. This concise resource by Dr. Linda Cox covers the full range of allergic disease, including aeroallergens, asthma, food allergies, atopic dermatitis, and stinging insects. With essential coverage of allergen immunotherapies in addition to key topics on emerging allergen-associated immunomodulators, this succinct, comprehensive reference consol…
Available Online
View e-Book
Other Authors
Cox, Linda S.
Responsibility
edited by Linda S. Cox
Place of Publication
Amsterdam, Netherlands
Publisher
Elsevier
Date of Publication
c2020
Physical Description
1 online resource, 400 p.
ISBN
9780323544276
Subjects (MeSH)
Hypersensitivity - therapy
Immunotherapy
Specialty
Allergy and Immunology
Abstract
Get a quick, expert overview of the use of current and novel immunotherapies for use in the management and treatment of allergic reactions and diseases. This concise resource by Dr. Linda Cox covers the full range of allergic disease, including aeroallergens, asthma, food allergies, atopic dermatitis, and stinging insects. With essential coverage of allergen immunotherapies in addition to key topics on emerging allergen-associated immunomodulators, this succinct, comprehensive reference consolidates today’s available information on this timely topic into a single convenient resource.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Immunotherapies for allergic disease

https://libcat.nshealth.ca/en/permalink/provcat50833
Cox, Linda S. (1st ed.) --Amsterdam, Netherlands: Elsevier , 2020.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Cox, Linda S.
Edition
1st ed.
Place of Publication
Amsterdam, Netherlands
Publisher
Elsevier
Date of Publication
2020
ISBN
9780323544276
Subjects (MeSH)
Hypersensitivity
Immunotherapy
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

32 records – page 1 of 2.